ArticleJMIR cancer2026

Immunotherapy Safety in Thymic Epithelial Tumors: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System.

Ruilian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.